Abstracts tagged "Disability"

Abstract Number: 2251 • 2014 ACR/ARHP Annual Meeting
Kneeling Disability Associated with the Treatment of Osteoarthritis: Analysis of a Copcord Study in Mexico
Alexia Hernández-Cáceres¹, Jacqueline Rodríguez-Amado¹, Ingris Peláez-Ballestas², David Vega-Morales³, Mario Garza-Elizondo¹, Roberto Negrete-López¹, Lorena Pérez-Barbosa¹ and Janett Riega-Torres¹, ¹Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Servicio de Reumatología, Departamento de Medicina Interna del Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Mexico, ²Departamento de Reumatología, Departamento de Reumatología Hospital General de México “Dr. Eduardo Liceaga”, Distrito Federal, Mexico, ³Rheumatology, Hospital Universitario UANL, Monterrey, Mexico
Background/Purpose Osteoarthritis (OA) is the most prevalent rheumatic disease in Mexico. The core treatment, a combination of pharmacological and non-pharmacological modalities, is mainly performed in…
Abstract Number: 2046 • 2014 ACR/ARHP Annual Meeting
Perceived Discrimination in Individuals with Radiographic Knee and Hip Osteoarthritis
Rebecca J. Cleveland¹, Jordan B. Renner², Joanne M. Jordan³ and Leigh F. Callahan⁴, ¹Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, ²University of North Carolina Department of Radiology, Chapel Hill, NC, ³University of North Carolina Dept of Epidemiology, Chapel Hill, NC, ⁴Thurston Arthritis Res Ctr, University of North Carolina, Chapel Hill, NC
Background/Purpose To describe the characteristics of participants who reported feelings of discrimination among a cohort of participants with radiographic osteoarthritis (rOA) of the knee and/or…
Abstract Number: 1412 • 2014 ACR/ARHP Annual Meeting
Sarcopenia and Its Impact on Disability in Rheumatoid Arthritis, a Pilot Study
Meltem Alkan Melikoglu¹ and Kazim Senel², ¹Rheumatology, Ataturk University Faculty of Medicine, Erzurum, Turkey, ²Physical Medicine and Rehabilitation, Ataturk University Medical School, Erzurum, Turkey
Background/Purpose: Rheumatoid arthritis (RA) is associated with increased morbidity and mortality due to several metabolic deteriorations one of which is sarcopenia. The aim of this…
Abstract Number: 1111 • 2014 ACR/ARHP Annual Meeting
The Effect of High Intensity Laser Therapy in the Management of Myofascial Pain Syndrome of the Trapezius: A Double Blind, Placebo-Controlled Study
Umit Dundar, Utku Turkmen, Hasan Toktas, Ozlem Solak and Alper Ulasli, Department of Physical Medicine and Rehabilitation, Afyon Kocatepe University, Faculty of Medicine, Afyonkarahisar, Turkey
The effect of high intensity laser therapy in the management of myofascial pain syndrome of the trapezius: a double blind, placebo-controlled studyAbstractBackground/Purpose: Myofascial pain syndrome…
Abstract Number: 1089 • 2014 ACR/ARHP Annual Meeting
Trajectories of Disability over Time Among Patients with Systemic Sclerosis
Sarah D. Mills¹, Rina S. Fox¹, Shadi Gholizadeh², Scott C. Roesch^1,3, Murray Baron^4,5, Marie Hudson^6,7, Russell Steele^6,8, Brett D. Thombs^6,9 and Vanessa L. Malcarne^1,10, ¹SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, ²Psychology, SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, ³Psychology, San Diego State University, San Diego, CA, ⁴Pavillion A, Rm 216, Jewish General Hospital, Montreal, QC, Canada, ⁵McGill University, Montreal, QC, Canada, ⁶Jewish General Hospital, Montreal, QC, Canada, ⁷Division of Rheumatology, McGill University, Montreal, QC, Canada, ⁸Mathematics, McGill University, Montreal, QC, Canada, ⁹Psychiatry, McGill University, Montreal, QC, Canada, ¹⁰San Diego State University, San Diego, CA
Background/Purpose Systemic Sclerosis (SSc) is often associated with disability, which worsens over time. However, there is considerable heterogeneity in the rate of patients’ disability progression.…
Abstract Number: 124 • 2013 ACR/ARHP Annual Meeting
Disability In Fibromyalgia Is Associated With Greater Self-Reported Symptoms and Functional Impairment
Emmanouil Rampakakis^1,2, Mary-Ann Fitzcharles³, Peter A. Ste-Marie⁴, John S. Sampalis^1,2 and Yoram Shir⁴, ¹JSS Medical Research, Montreal, QC, Canada, ²Jewish General Hospital, McGill University, Montreal, QC, Canada, ³Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, ⁴Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: It is intuitive that disablement due to illness should be reflected in illness severity. When illness measurement is based on subjective report only, without…
Abstract Number: 2292 • 2013 ACR/ARHP Annual Meeting
Factors Affecting The Discrepancy Between Physician and Patient Global Assessment Of Disease Activity In Early and Established Rheumatoid Arthritis Patients- Results From The Ontario Best Practices Initiative
Pooneh Akhavan¹, Binu Jacob², Edward C. Keystone^3,4, Xiuying Li⁵, J. Carter Thorne⁶ and Claire Bombardier⁷, ¹Medicine, Early Rheumatoid Arthritis Program, Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, ²University Health Network, Toronto General Research Institute, Toronto, ON, Canada, ³Rebecca MacDonald Centre for Arthritis and Autoimmune Disease, Mount Sinai Hospital, Toronto, ON, Canada, ⁴University of Toronto/Mount Sinai Hospital, Toronto, ON, Canada, ⁵Clinical Decision Making and Health Care, University Health Network, Toronto, ON, Canada, ⁶Southlake Regional Health Centre, Newmarket, ON, Canada, ⁷Rheumatology, University of Toronto, Toronto, ON, Canada
Background/Purpose: Discrepancy between patient (PGA) and physician (MDGA) global assessments in Rheumatoid Arthritis (RA) can adversely affect therapeutic decisions. The pattern of PGA and MDGA,…
Abstract Number: 2090 • 2013 ACR/ARHP Annual Meeting
The Effects of Commercially Available Footwear On Foot Pain and Disability in People With Gout: A Feasibility Study
Keith Rome¹, Sarah Stewart², Alain Vandal^3,4, Peter J. Gow⁵, Peter J. McNair² and Nicola Dalbeth⁶, ¹Health & Rehabilitation Research Institute, Auckland, New Zealand, AUT University, Auckland, New Zealand, ²Health & Rehabilitation Research Institute, AUT University, Auckland, New Zealand, ³Faculty of Health and Environmental Sciences, AUT University, Auckland, New Zealand, ⁴Counties Manukau District Health Board, Auckland, New Zealand, ⁵Rheumatology Dept, Middlemore Hospital, Auckland, New Zealand, ⁶Medicine, University of Auckland, Auckland, New Zealand
Background/Purpose: The non-pharmacological management goals for people with foot-related rheumatic diseases are pain management, preservation of foot function and patient mobility. One of the therapeutic…
Abstract Number: 1989 • 2013 ACR/ARHP Annual Meeting
Determinants Of Functional Disability In Patients With Gout: Longitudinal Analysis From a Multicentre Observational Study Of The Italian Society For Rheumatology
Carlo Alberto Scirè¹, Maria Manara¹, Greta Carrara¹, Marco A. Cimmino², Marcello Govoni³, Fausto Salaffi⁴, Leonardo Punzi⁵, Carlomaurizio Montecucco⁶, Marco Matucci-Cerinic⁷ and Giovanni Minisola⁸, ¹Epidemiology Unit -Italian Society for Rheumatology, Milano, Italy, ²Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, ³Clinical and Experimental Medicine, Section of Rheumatology, University of Ferrara, Ferrara, Italy, ⁴Rheumatology Unit - Polytechnic University of the Marche, Jesi, Italy, ⁵Department of Medicine - DIMED, University of Padova, Padova, Italy, ⁶Rheumatology, University and IRCCS Policlinico S. Matteo Foundation, Pavia, Italy, ⁷Rheumatology, University of Florence, Azienda Ospedaliera Careggi, Florence, Italy, ⁸Rheumatology Unit, San Camillo-Forlanini Hospital, Rome, Italy
Background/Purpose: Gout is the most prevalent arthritis and significantly impacts on function. Beside the influence of concurrent comorbidities, identifying disease-related prognostic factors may help to…
Abstract Number: 1791 • 2013 ACR/ARHP Annual Meeting
Reaching The Target Of Low Disease Activity At 6 Months Predicts Better Long-Term Functional Outcome In Patients With Early Rheumatoid Arthritis
Pooneh Akhavan¹, Bindee Kuriya², Edward C. Keystone^3,4, Juan Xiong⁵, Janet E. Pope⁶, Gilles Boire⁷, Diane Tin⁸, Boulos Haraoui⁹, Carol A. Hitchon¹⁰ and Vivian P. Bykerk^11,12, ¹Medicine, Early Rheumatoid Arthritis Program, Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, ²Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ³Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ⁴Rebecca MacDonald Centre for Arthritis and Autoimmune Disease, Mount Sinai Hospital, Toronto, ON, Canada, ⁵Mount Sinai Hospital, Toronto, ON, Canada, ⁶St Joseph Health Care, London, ON, Canada, ⁷Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada, ⁸The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ⁹Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada, ¹⁰Rheumatology, University of Manitoba, Winnipeg, MB, Canada, ¹¹Medicine, Mount Sinai Hospital/University of Toronto, Toronto, ON, Canada, ¹²Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY
Background/Purpose: Current clinical practice guidelines recommend remission, and if not possible, low disease activity (LDA) as the treatment target in rheumatoid arthritis (RA). Patients should…
Abstract Number: 1779 • 2013 ACR/ARHP Annual Meeting
A Randomized Controlled, Clinical, Histological and mRNA Profiling Pilot Study Of Endurance Exercise In Myositis
Li Alemo Munters^1,2, Ingela M. Loell³, Joan Raouf⁴, Maryam Dastmalchi³, Eva Lindroos⁵, Christina Ottosson⁶, Yi-Wen Chen⁷, Annemarie F van Delden⁸, Mona Esbjörnsson⁹, Marina Korotkova¹⁰, Helene Alexanderson¹¹, Kanneboyina Nagaraju¹² and Ingrid E. Lundberg¹³, ¹Department of Medicine, Rheumatology Unit, , Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden, ²Department of Physiotherapy, Rheumatology Unit, Karolinska University Hospital in Solna, Stockholm, Sweden, Stockholm, Sweden, ³Rheumatology Unit, Department of Medicine, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden, ⁴Department of Medicine, Rheumatology Unit, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, ⁵Department of Medicine, Rheumatology Unit, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden., Stockholm, Sweden, ⁶Department of Medicine, Rheumatology Unit, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden., Stockholm, Sweden, ⁷Research Center for Genetic Medicine, Children’s National Medical Center, Washington DC, USA., Washington DC, DC, ⁸Department of Medicine,, Rheumatology Unit, Karolinska University Hospital Solna, Karolinska Institutet, Stockholm, Sweden., Stockholm, Sweden, ⁹Department of Physiology, Karolinska Institutet, Huddinge, Sweden, ¹⁰Department of Medicine, Rheumatology Unit, Department of Medicine, Karolinska University Hospital in Solna, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, ¹¹Department of Neurobiology, Care Science and Society, Division of Physiotherapy, Division of Physiotherapy, Karolinska Institutet, Huddinge, Stockholm, Sweden, ¹²Research Center for Genetic Medicine, Children’s National Medical Center, Washington DC, DC, ¹³Rheumatology Unit, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden
Background/Purpose: This pilot study is a hypothesis-driven exploratory part of a larger randomized controlled trial evaluating effects of a supervised 12-week endurance exercise program (EG)…
Abstract Number: 1306 • 2013 ACR/ARHP Annual Meeting
Do Sustained Clinical Remission and Sustained Low Disease Activity Equally Predict Functional Status In Early Rheumatoid Arthritis?
Bindee Kuriya¹, Juan Xiong², Gilles Boire³, Boulos Haraoui⁴, Carol A. Hitchon⁵, Janet E. Pope⁶, J. Carter Thorne⁷, Diane Tin⁸, Edward C. Keystone⁹, Cheryl Barnabe¹⁰, Pooneh Akhavan¹¹ and Vivian P. Bykerk¹², ¹Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ²Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ³Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada, ⁴Rheumatology, Institut de Rhumatologie de Montréal, Montreal, QC, Canada, ⁵University of Manitoba, Winnipeg, MB, Canada, ⁶Rheumatology, St Joseph Health Centre, London, ON, Canada, ⁷Southlake Regional Health Centre, Newmarket, ON, Canada, ⁸The Arthritis Program, Southlake Regional Health Centre, Newmarket, ON, Canada, ⁹Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ¹⁰Medicine, Community Health Sciences, University of Calgary, Calgary, AB, Canada, ¹¹Medicine, Early Rheumatoid Arthritis Program, Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, ¹²Divison of Rheumatology, Hospital for Special Surgery, New York, NY
Background/Purpose: Sustained clinical remission (REM) is the therapeutic goal in rheumatoid arthritis (RA) but low disease activity (LDA) may be acceptable. Little is known…
Abstract Number: 250 • 2013 ACR/ARHP Annual Meeting
Synovial Inflammation In Meniscal Tear Patients: CCL19 mRNA Expression Is Independently Associated With Knee Related Disability
Anjali Nair¹, Charles Bush-Joseph², Nikhil Verma², Matthew Tetreault², Kanta Saha³, Arkady Margulis⁴, Louis F. Fogg⁵ and Carla R. Scanzello³, ¹Section of Rheumatology, Rush University Medical Center, Chicago, IL, ²Orthopedics, Rush University Medical Center, Chicago, IL, ³Rheumatology, Rush University Medical Center, Chicago, IL, ⁴Rush University Medical Center, Chicago, IL, ⁵Department of Nursing, Rush University Medical Center, Chicago, IL
Background/Purpose: In patients with knee osteoarthritis (OA), synovitis is associated with severity of knee symptoms. Previously, we demonstrated that in patients undergoing partial meniscectomy without…
Abstract Number: 251 • 2013 ACR/ARHP Annual Meeting
Physical Activity Is Associated With Reduced Incident Disability: Evidence From The Osteoarthritis Initiative
Dorothy D. Dunlop¹, Jing Song¹, Pamela A. Semanik², Leena Sharma², Joan M. Bathon³, Charles Eaton⁴, Marc C. Hochberg⁵, Rebecca D. Jackson⁶, C. Kent Kwoh⁷, W, Jerry Mysiw⁶, Michael C. Nevitt⁸ and Rowland W. Chang¹, ¹Northwestern University Feinberg School of Medicine, Chicago, IL, ²Northwestern University, Chicago, IL, ³Columbia University, New York, NY, ⁴Center for Primary Care and Prevention, Memorial Hospital of Rhode Island, Providence, RI, ⁵Medicine, University of Maryland School of Medicine, Baltimore, MD, ⁶Ohio State University, Columbus, OH, ⁷School of Medicine, Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ⁸Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA
Background/Purpose: Over 56 million people in the U.S. are classified as disabled. Physical activity is a low cost, broadly applicable approach to improve cardiovascular fitness,…
Abstract Number: 1825 • 2012 ACR/ARHP Annual Meeting
Work Disability and Work Limitations in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Are Equal and Increase with Comorbidities
Chanseok Rhee¹, Janet E. Pope², Andrew E. Thompson³, Nicole G. H. Le Riche⁴, Gina Rohekar⁵ and Sherry Rohekar⁵, ¹School of Medicine and Dentistry, Schulich School of Medicine and Dentisty, Western University, London, ON, Canada, ²Medicine/Rheumatology, St. Joseph Health Care London, University of Western Ontario, London, ON, Canada, ³Rheumatology, St. Josephs Health Ctr, London, ON, Canada, ⁴Department of Medicine, St. Joseph's Hospital, London, ON, Canada, ⁵Rheumatology, St. Joseph's Hospital, London, ON, Canada
Background/Purpose: Few studies directly compare work disability (WD) and work productivity losses in different forms of inflammatory arthritis (IA) such as rheumatoid arthritis (RA), psoriatic…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.